Metropolitan Life Insurance Company (MetLife)’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-681	Closed	-$81.4K	–	2575
2020 Q3	$81.4K	Buy	681 +147	+28%	+$17.6K	﹤0.01%	2337
2020 Q2	$66.5K	Buy	+534	New	+$66.5K	﹤0.01%	2458